KVUE - Kenvue Inc.
Close
20.97
0.035 0.167%
Share volume: 12,681,979
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Toilet Preparation Manufacturing:
2.90%
PREVIOUS CLOSE
CHG
CHG%
$20.94
0.12
0.01%
Fundamental analysis
84%
Profitability
88%
Dept financing
45%
Liquidity
43%
Performance
100%
Performance
5 Days
0.58%
1 Month
-4.98%
3 Months
-2.92%
6 Months
15.79%
1 Year
-1.22%
2 Year
-22.04%
Key data
Stock price
$20.97
DAY RANGE
$20.70 - $21.09
52 WEEK RANGE
$17.94 - $24.46
52 WEEK CHANGE
-$1.22
DIVIDEND
$0.205
EX-DIVIDEND DATE
08/14/2024
NEXT EARNINGS DATE
N/A
Company detail
CEO: Thibaut Mongon
Region: US
Website: www.jnj.com/kenvue/
Employees: 0
IPO year: 2023
Issue type: Common Stock
Market: NYSE
Industry: Toilet Preparation Manufacturing
Sector: Manufacturing
Region: US
Website: www.jnj.com/kenvue/
Employees: 0
IPO year: 2023
Issue type: Common Stock
Market: NYSE
Industry: Toilet Preparation Manufacturing
Sector: Manufacturing
We are the world’s largest pure-play consumer health company by revenue with $15.0 billion in net sales in 2022. We combine the power of science with meaningful human insights and digital-first capabilities, which we believe empowers approximately 1.2 billion people to live healthier lives every day. Prior to the completion of this offering, we are a wholly owned subsidiary of Johnson & Johnson. Our principal executive offices are located at 199 Grandview Road, Skillman, NJ.
Recent news